PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg 48,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg 120,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, and immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10).

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
Product Citations
  1. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  2. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  3. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  4. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  5. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  6. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  7. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  8. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  9. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  10. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  11. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  12. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  13. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  14. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  15. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  16. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  17. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  18. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  19. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  20. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  21. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  22. Bussey KA, et al. 2019. J Virol. 93. PubMed
  23. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  24. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  25. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  26. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  27. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  28. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  29. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  30. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  31. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  32. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  33. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  34. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  35. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  36. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  37. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  38. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  39. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  40. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  41. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  42. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  43. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  44. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  45. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  46. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  47. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  48. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  49. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  50. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  51. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  52. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  53. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  54. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  55. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  56. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  57. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  58. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  59. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  60. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  61. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  62. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  63. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  64. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  65. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  66. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  67. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  68. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  69. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  70. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  71. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  72. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  73. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  74. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  75. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  76. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  77. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  78. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  79. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  80. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  81. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  82. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  83. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  84. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  85. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  86. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  87. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  88. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  89. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  90. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  91. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  92. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  93. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  94. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  95. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  96. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  97. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  98. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  99. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  100. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  101. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  102. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  103. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  104. De Simone G, et al. 2021. Immunity. :. PubMed
  105. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  106. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  107. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  108. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  109. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  110. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  111. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  112. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  113. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  114. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  115. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  116. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account